Use of DRS Probe and Tracking for In-vivo Application
Gastrointestinal Cancer
About this trial
This is an interventional diagnostic trial for Gastrointestinal Cancer focused on measuring cancer, artificial intelligence, diffuse reflectance spectroscopy, gastrointestinal
Eligibility Criteria
Inclusion Criteria: Patients undergoing primary upper GI cancer resection surgery Patients undergoing primary lower GI (colorectal) cancer resection surgery Patients >18 years of age Patients who consent to take part in the study Exclusion Criteria: Patients who do not consent to the study or decline to participate Patients who do not meet the inclusion criteria Patients who lack capacity Patients undergoing emergency lower or upper GI cancer surgery Patients undergoing re-operation for cancer surgery Pregnant women
Sites / Locations
- Imperial College NHS TrustRecruiting
Arms of the Study
Arm 1
Experimental
DRS in-vivo
Participants (patients undergoing GI cancer surgery) will have a DRS probe used on the in-vivo tissue for 5-10 minutes during a single operation